سنتز

جستارهای وابسته

منابع

1. ↑Dictionary of organic compounds. London: Chapman & Hall. 1996.ISBN 0-412-54090-8.
2. ↑Cecchini S, Petri P, Ardito R, Bareggi SR, Torriti A (1978). "A comparative double-blind trial of the new antidepressant caroxazone and amitriptyline".The Journal of International Medical Research.6 (5): 388–94.doi:10.1177/030006057800600507.PMID 359383.S2CID 40464443.
3. ↑Monoamine oxidase inhibitors in neurological diseases. New York: M. Dekker. 1994.ISBN 0-8247-9082-0.
4. ↑Moretti A, Caccia C, Martini A, Bonollo L, Amico A, Sega R, et al. (May 1981)."Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers".British Journal of Clinical Pharmacology.11 (5): 511–5.doi:10.1111/j.1365-2125.1981.tb01158.x.PMC 1401585.PMID 7272163.
5. ↑Moretti A, Caccia C, Calderini G, Menozzi M, Amico A (October 1981). "Studies on the mechanism of action of caroxazone, a new antidepressant drug".Biochemical Pharmacology.30 (19): 2728–31.doi:10.1016/0006-2952(81)90549-9.PMID 6170295.
6. ↑Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A (June 1981)."Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man".British Journal of Clinical Pharmacology.11 (6): 611–5.doi:10.1111/j.1365-2125.1981.tb01178.x.PMC 1402186.PMID 7272178.
7. ↑Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A, Braibanti E (June 1981)."Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man".British Journal of Clinical Pharmacology.11 (6): 605–10.doi:10.1111/j.1365-2125.1981.tb01177.x.PMC 1402193.PMID 7272177.
8. ↑Bernardi L, Coda S, Nicolella V, Vicario GP, Gioia B, Minghetti A, et al. (1979). "Radioisotopic and synthetic studies related to caroxazone metabolism in man".Arzneimittel-Forschung.29 (9): 1412–6.PMID 583252.
9. ↑Bernardi L, Coda S, Pegrassi L, Suchowsky GK (August 1968). "Pharmacological properties of some derivatives of 1,3-benzoxazine".Experientia.24 (8): 774–5.doi:10.1007/bf02144859.PMID 5683159.S2CID 30917127.
10. ↑Bernardi L, Coda S, Bonsignori A, Pegrassi L, Suchowsky GK (August 1969)."Central depressant properties of 3,1-benzoxazine derivates".Experientia.25 (8): 787–8.doi:10.1007/bf01897874.PMID 5348526.S2CID 5347811.
11. ↑GB 1115759 ; L. Bernardi et al. ,U.S. Patent ۳٬۴۲۷٬۳۱۳ (1965, 1969 both to Soc. Farma. Italia).